3,5-dimethoxy-4'-hydroxy-trans-stilbene
Small moleculeexperimental
Pterostilbene (trans-3,5-dimethoxy-4-hydroxystilbene) is a stilbenoid chemically related to resveratrol. In plants, it serves a defensive phytoalexin role. — Wikipedia
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2017 (NCT03489200)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPterostilbene ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03489200 | N/A | Jan 31, 2017 | Elysium Health, Fundación Universidad Católica de Valencia San Vicente Mártir, University of Valencia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Elysium Health | For profit | 1 | 1 | 1 | 2017 |
| Fundación Universidad Católica de Valencia San Vicente Mártir | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Valencia | Academic/Hospital | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1